Elevation Long Term Debt from 2010 to 2025
| ELEV Stock | USD 0.28 0.01 1.72% |
Long Term Debt | First Reported 2010-12-31 | Previous Quarter 31.1 M | Current Value 33.3 M | Quarterly Volatility 1 M |
Check Elevation Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevation Oncology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 33.3 K, Interest Expense of 1.1 M or Selling General Administrative of 10.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.56. Elevation financial statements analysis is a perfect complement when working with Elevation Oncology Valuation or Volatility modules.
Elevation | Long Term Debt |
Latest Elevation Oncology's Long Term Debt Growth Pattern
Below is the plot of the Long Term Debt of Elevation Oncology over the last few years. Long-term debt is a debt that Elevation Oncology has held for over one year. Long-term debt appears on Elevation Oncology balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Elevation Oncology balance sheet is the sum of the balances of all categories of long-term debt. It is debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years. Elevation Oncology's Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevation Oncology's overall financial position and show how it may be relating to other accounts over time.
| Long Term Debt | 10 Years Trend |
|
Long Term Debt |
| Timeline |
Elevation Long Term Debt Regression Statistics
| Arithmetic Mean | 29,824,054 | |
| Geometric Mean | 29,808,641 | |
| Coefficient Of Variation | 3.42 | |
| Mean Deviation | 632,213 | |
| Median | 29,435,000 | |
| Standard Deviation | 1,019,135 | |
| Sample Variance | 1T | |
| Range | 3.8M | |
| R-Value | 0.60 | |
| Mean Square Error | 713.8B | |
| R-Squared | 0.36 | |
| Significance | 0.01 | |
| Slope | 128,187 | |
| Total Sum of Squares | 15.6T |
Elevation Long Term Debt History
Other Fundumenentals of Elevation Oncology
About Elevation Oncology Financial Statements
Elevation Oncology investors use historical fundamental indicators, such as Elevation Oncology's Long Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevation Oncology. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 31.1 M | 33.3 M | |
| Long Term Debt | 31.1 M | 33.3 M | |
| Long Term Debt Total | 26.5 M | 23.5 M | |
| Long Term Debt To Capitalization | 0.34 | 0.40 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Elevation Stock Analysis
When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.